Skip to main content
. 2001 Sep;52(3):273–278. doi: 10.1046/j.0306-5251.2001.01449.x

Figure 1.

Figure 1

Individual concentration-time profiles of MMC in plasma during a 60-min intravesical instillation. Group 1, ICT (20 mg) combined with hyperthermia; group 2, ICT alone at the same dose as group 1; group 3, ICT (40 mg) combined with hyperthermia; group 4, ICT alone at the same dose as group 3.